COVID-19 update included
The content of this report will be updated with the latest scenarios based on the global COVID-19 Pandemic

The global transfer membrane market is expected to witness CAGR of 1.5% over the forecast period. The market is primarily driven by the increasing investment in R&D by the pharmaceutical and biopharmaceutical companies and development of new therapeutics for targeting chronic diseases. Furthermore, the growing prevalence of autoimmune diseases, infectious diseases and increasing focus on the development of novel drug therapies based on DNA and RNA are projected to boost the market growth over the forecast period.

However, the availability of the alternative methods for the protein transfer with high efficiency and automation are projected to hamper the market growth. Moreover, the advancements in membrane transfer technologies such as greater straining capabilities and compatibility of a variety of detection chemicals projected to fuel the market growth.

Key Market Trends


PVDF Segment Expected to have Lucrative Growth

PVDF transfer membranes are the hydrophobic membranes that are widely used in western blotting techniques. PVDF segment is anticipated to grow at significant rates over the forecast period. The growth of the market is attributed to advantages of PVDF membranes such as better retention, chemical compatibility and strength of the membrane. In the End-User segment, Academic Research institutions are anticipated to have considerable growth owing to the increased R&D investments by public and privates organizations in science research. Moreover, the huge pipeline of therapeutics that uses protein analysis are expected to boost the market growth over the forecast period

In the application segment, western blotting is anticipated to grow at notable rates. The growth is attributed to the increasing prevalence of allergies, autoimmune diseases, and infectious diseases and availability of products.

Moreover, increasing investment in healthcare coupled with the increasing accessibility of the drugs fuel the R&D further boost the market growth.

North America Expected to have Significant Market Share

North America region is anticipated to have significant market share owing to a large number of R&D activities, huge investments in the development of new drugs and support from the public and private organizations on research. Moreover, the growing prevalence of the chronic diseases coupled with rising targeted diseases in the region is anticipated to boost the regional growth. Growing research in life sciences, increasing investments in proteomics and growing number of regional players is projected to fuel the Asia Pacific regional market over the forecast period.

Competitive Landscape


Global transfer membrane market is moderately competitive. Market players are focusing on new product launches, product innovations and geographical expansion. The key market players operating in the market include Merck KGaA, PerkinElmer, Inc., Pall Corporation, Thermo Fisher Scientific and Bio-Rad Laboratories, Inc. among others.

Reasons to Purchase this report:

  • The market estimate (ME) sheet in Excel format
  • Report customization as per the client’s requirements
  • 3 months of analyst support